Catabasis Pharmaceuticals Inc.
Close the PIPE offering
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 29 Jan 2021
- Due
- 1 Feb 2021
- Delivered
- 1 Feb 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The PIPE offering is expected to close on February 1, 2021.”
What we found
Evidence strength A What the grades mean
The company successfully closed the PIPE offering on the scheduled date of February 1, 2021, raising approximately $110 million in gross proceeds.
-
A Catabasis Pharmaceuticals Inc. 10-Q filed 2021-05-13
“we sold an aggregate of 35,573 shares of Series X Preferred Stock on the February 1, 2021 closing date for gross proceeds of approximately $110.0 million” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Transaction other
- Indicative materiality
- Medium rules
- Action
- Close
- Deliverable
- PIPE offering
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Conditional
- Yes: subject to stockholder approval
- Depends on
- Financing
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Catabasis Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C454789-022642 · Corrections policy